Astera Labs (ALAB) Cash & Equivalents (2023 - 2026)

Astera Labs (ALAB) has 4 years of Cash & Equivalents data on file, last reported at $148.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 71.56% year-over-year to $148.3 million; the trailing twelve-month figure through Mar 2026 stood at $148.3 million (up 71.56% YoY), and the FY2025 full-year result was $167.6 million, up 110.7% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $148.3 million, down from $167.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $696.1 million in Q1 2024 and bottomed at $45.1 million in Q4 2023.
• A 4-year average of $207.3 million and a median of $144.3 million in 2025 frame the typical range for Cash & Equivalents.
• Peak annual rise in Cash & Equivalents reached 110.7% in 2025, while the deepest fall reached 87.58% in 2025.
• Tracing ALAB's Cash & Equivalents over 4 years: stood at $45.1 million in 2023, then jumped by 76.4% to $79.6 million in 2024, then surged by 110.7% to $167.6 million in 2025, then slipped by 11.53% to $148.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $148.3 million, $167.6 million, and $140.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison